Dr. LM Larratt is currently appointed as Professor in the Division of Hematology (DoM) in the Faculty of Medicine and Dentistry.
Acute and chronic leukemia
, myeloproliferative disorders, aplastic anemia
and PNH and ITP
4918.75 funds in 2013, cll, chemotherapy, collecting longitudinal prospective data on all pt, comparing std vs extended life eculuzimab for trea, enrolling patients in registry with atypical hus, MDS, placebo controlled trial with revlimid, Phase 4 trial to study safety of romiplostim in pt, studying safety of attenuated vaccine vs placebo i, transplantation